Longevity · Longevity peptide (research)
SS-31 (Elamipretide)
- Drug class
- Longevity peptide (research)
- Status
- Compounded (503A)
- Also known as
- elamipretide, mtp-131, bendavia, ss31, ss 31, mitochondrial peptide
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What SS-31 (Elamipretide) is studied for
- Mitochondrial function (research)
- Cellular energy (research)
- Cardiolipin protection (research)
Mechanism of action
SS-31 (Elamipretide) is being studied in the longevity category. Mitochondrial-targeted peptide studied for cellular energy and longevity. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is SS-31 (Elamipretide)?
SS-31 (Elamipretide) is a longevity peptide. Mitochondrial-targeted peptide studied for cellular energy and longevity.
What is SS-31 (Elamipretide) studied for?
Published research has examined SS-31 (Elamipretide) for mitochondrial function, cellular energy, cardiolipin protection. Human clinical evidence varies by indication.
Is SS-31 (Elamipretide) FDA-approved?
No. SS-31 (Elamipretide) is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is SS-31 (Elamipretide) used in research?
Protocols vary by study. SS-31 (Elamipretide) is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for SS-31 (Elamipretide) is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.